Indo US Bio Tech Ltd — Quarterly Results & Earnings

₹98.21

-0.51%

Profit Growth YoY-20.87%Latest quarter

Sales Growth YoY39.15%Latest quarter

Sales CAGR 5Y21.17%5 year compound

Profit CAGR 5Y44.98%5 year compound

📋

Quarterly Performance

YoY Profit Growth-20.87%

🔴 Significant decline

YoY Sales Growth+39.15%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

15.82%

EPS Growth 5Y

35.88%

Interest Coverage

Higher = safer debt servicing

12.44

ROE

23.03%

ROCE

21.15%

💡

Growth Analysis

Indo US Bio Tech Ltd reported YoY profit growth of -20.87% and revenue growth of 39.15% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 21.17% and profits at 44.98% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Indo US Bio Tech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Other Agricultural Products Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.